BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 20721781)

  • 1. A comparison of multiple testing procedures for the gold standard non-inferiority trial.
    Röhmel J; Pigeot I
    J Biopharm Stat; 2010 Sep; 20(5):911-26. PubMed ID: 20721781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Many-to-one comparison after sample size reestimation for trials with multiple treatment arms and treatment selection.
    Wang J
    J Biopharm Stat; 2010 Sep; 20(5):927-40. PubMed ID: 20721782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing non-inferiority of a new treatment in a three-arm clinical trial including a placebo.
    Pigeot I; Schäfer J; Röhmel J; Hauschke D
    Stat Med; 2003 Mar; 22(6):883-99. PubMed ID: 12627407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bio-creep in non-inferiority clinical trials.
    Everson-Stewart S; Emerson SS
    Stat Med; 2010 Nov; 29(27):2769-80. PubMed ID: 20809482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A two-stage sample size recalculation procedure for placebo- and active-controlled non-inferiority trials.
    Schwartz TA; Denne JS
    Stat Med; 2006 Oct; 25(19):3396-406. PubMed ID: 16900573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On non-inferiority analysis based on delta-method confidence intervals.
    Rothmann MD; Tsou HH
    J Biopharm Stat; 2003 Aug; 13(3):565-83. PubMed ID: 12921402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some fundamental issues with non-inferiority testing in active controlled trials.
    James Hung HM; Wang SJ; Tsong Y; Lawrence J; O'Neil RT
    Stat Med; 2003 Jan; 22(2):213-25. PubMed ID: 12520558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modified Haybittle-Peto group sequential designs for testing superiority and non-inferiority hypotheses in clinical trials.
    Lai TL; Shih MC; Zhu G
    Stat Med; 2006 Apr; 25(7):1149-67. PubMed ID: 16189814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-parametric assessment of non-inferiority with censored data.
    Freitag G; Lange S; Munk A
    Stat Med; 2006 Apr; 25(7):1201-17. PubMed ID: 16345041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A note on the conservativeness of the confidence interval approach for the selection of non-inferiority margin in the two-arm active-control trial.
    Sankoh AJ
    Stat Med; 2008 Aug; 27(19):3732-42. PubMed ID: 18407575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Group sequential test strategies for superiority and non-inferiority hypotheses in active controlled clinical trials.
    Wang SJ; Hung HM; Tsong Y; Cui L
    Stat Med; 2001 Jul; 20(13):1903-12. PubMed ID: 11427948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and analysis of non-inferiority mortality trials in oncology.
    Rothmann M; Li N; Chen G; Chi GY; Temple R; Tsou HH
    Stat Med; 2003 Jan; 22(2):239-64. PubMed ID: 12520560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The assessment of non-inferiority in a gold standard design with censored, exponentially distributed endpoints.
    Mielke M; Munk A; Schacht A
    Stat Med; 2008 Nov; 27(25):5093-110. PubMed ID: 18570271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple-arm superiority and non-inferiority designs with various endpoints.
    Chang M
    Pharm Stat; 2007; 6(1):43-52. PubMed ID: 17323311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methods for one-sided testing of the difference between proportions and sample size considerations related to non-inferiority clinical trials.
    Dann RS; Koch GG
    Pharm Stat; 2008; 7(2):130-41. PubMed ID: 17526060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninferiority testing beyond simple two-sample comparison.
    Tsong Y; Chen WJ
    J Biopharm Stat; 2007; 17(2):289-308. PubMed ID: 17365225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testing for qualitative interactions between stages in an adaptive study.
    Parker RA
    Stat Med; 2010 Jan; 29(2):210-8. PubMed ID: 19908261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing non-inferiority and superiority for two endpoints for several treatments with a control.
    Lawrence J
    Pharm Stat; 2011; 10(4):318-24. PubMed ID: 20949636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TACT method for non-inferiority testing in active controlled trials.
    Wang SJ; Hung HM
    Stat Med; 2003 Jan; 22(2):227-38. PubMed ID: 12520559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Test for the consistency of noninferiority from multiple clinical trials.
    Yan X; Wang MC; Su X
    J Biopharm Stat; 2007; 17(2):265-78. PubMed ID: 17365223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.